Novo Nordisk A/S (NVO)
36.85
-0.13
(-0.35%)
USD |
NYSE |
Apr 06, 11:21
Novo Nordisk Market Cap : 165.80B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 30.41M |
| Ascendis Pharma A/S | 14.11B |
| Viking Therapeutics, Inc. | 4.265B |
| DBV Technologies SA | 1.167B |
| Cellectis SA | 357.22M |
Market Cap Related Metrics
| PE Ratio | 10.63 |
| PS Ratio | 3.509 |
| PEG Ratio | 1.881 |
| Price to Book Value | 7.070 |
| Price to Free Cash Flow | 37.27 |
| Price | 36.85 |
| Earnings Yield | 9.41% |
| PEGY Ratio | 1.010 |
| Operating PE Ratio | 8.523 |
| Normalized PE Ratio | 10.63 |